Smith G - Search Results

1

Regulation of cytochrome P450 gene expression in human colon and breast tumour xenografts.

Smith G, Harrison DJ, East N, Rae F, Wolf H, Wolf CR. Smith G, et al. Br J Cancer. 1993 Jul;68(1):57-63. doi: 10.1038/bjc.1993.286. Br J Cancer. 1993. PMID: 8318421 Free PMC article.

2

Factors influencing the cellular accumulation of SN-38 and camptothecin.

Cummings J, Boyd G, Macpherson JS, Wolf H, Smith G, Smyth JF, Jodrell DI. Cummings J, et al. Among authors: smith g. Cancer Chemother Pharmacol. 2002 Mar;49(3):194-200. doi: 10.1007/s00280-001-0393-3. Epub 2002 Jan 22. Cancer Chemother Pharmacol. 2002. PMID: 11935211

3

ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells.

Vaidyanathan A, Sawers L, Gannon AL, Chakravarty P, Scott AL, Bray SE, Ferguson MJ, Smith G. Vaidyanathan A, et al. Among authors: smith g. Br J Cancer. 2016 Aug 9;115(4):431-41. doi: 10.1038/bjc.2016.203. Epub 2016 Jul 14. Br J Cancer. 2016. PMID: 27415012 Free PMC article.

4

Quantitative real-time reverse transcription-polymerase chain reaction analysis of drug metabolizing and cytoprotective genes in psoriasis and regulation by ultraviolet radiation.

Smith G, Dawe RS, Clark C, Evans AT, Comrie MM, Wolf CR, Ferguson J, Ibbotson SH. Smith G, et al. J Invest Dermatol. 2003 Aug;121(2):390-8. doi: 10.1046/j.1523-1747.2003.12354.x. J Invest Dermatol. 2003. PMID: 12880432

5

Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases.

Smith G, Wolf CR, Deeni YY, Dawe RS, Evans AT, Comrie MM, Ferguson J, Ibbotson SH. Smith G, et al. Lancet. 2003 Apr 19;361(9366):1336-43. doi: 10.1016/S0140-6736(03)13081-4. Lancet. 2003. PMID: 12711469 Clinical Trial.

6

Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.

Sachse C, Bhambra U, Smith G, Lightfoot TJ, Barrett JH, Scollay J, Garner RC, Boobis AR, Wolf CR, Gooderham NJ; Colorectal Cancer Study Group. Sachse C, et al. Among authors: smith g. Br J Clin Pharmacol. 2003 Jan;55(1):68-76. doi: 10.1046/j.1365-2125.2003.01733.x. Br J Clin Pharmacol. 2003. PMID: 12534642 Free PMC article.

7

A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.

Sachse C, Smith G, Wilkie MJ, Barrett JH, Waxman R, Sullivan F, Forman D, Bishop DT, Wolf CR; Colorectal Cancer Study Group. Sachse C, et al. Among authors: smith g. Carcinogenesis. 2002 Nov;23(11):1839-49. doi: 10.1093/carcin/23.11.1839. Carcinogenesis. 2002. PMID: 12419832

8

Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivity.

Deeni YY, Ibbotson SH, Woods JA, Wolf CR, Smith G. Deeni YY, et al. Among authors: smith g. PLoS One. 2013 Sep 23;8(9):e75494. doi: 10.1371/journal.pone.0075494. eCollection 2013. PLoS One. 2013. PMID: 24086543 Free PMC article.

9

Mutations of APC, K-ras, and p53 are associated with specific chromosomal aberrations in colorectal adenocarcinomas.

Leslie A, Pratt NR, Gillespie K, Sales M, Kernohan NM, Smith G, Wolf CR, Carey FA, Steele RJ. Leslie A, et al. Among authors: smith g. Cancer Res. 2003 Aug 1;63(15):4656-61. Cancer Res. 2003. PMID: 12907646

10

Chromosomal changes in colorectal adenomas: relationship to gene mutations and potential for clinical utility.

Leslie A, Stewart A, Baty DU, Mechan D, McGreavey L, Smith G, Wolf CR, Sales M, Pratt NR, Steele RJ, Carey FA. Leslie A, et al. Among authors: smith g. Genes Chromosomes Cancer. 2006 Feb;45(2):126-35. doi: 10.1002/gcc.20271. Genes Chromosomes Cancer. 2006. PMID: 16235243

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results